163 related articles for article (PubMed ID: 38608213)
1. Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application.
Mikolajewicz N; Yee PP; Bhanja D; Trifoi M; Miller AM; Metellus P; Bagley SJ; Balaj L; de Macedo Filho LJM; Zacharia BE; Aregawi D; Glantz M; Weller M; Ahluwalia MS; Kislinger T; Mansouri A
J Clin Oncol; 2024 Jun; 42(16):1961-1974. PubMed ID: 38608213
[TBL] [Abstract][Full Text] [Related]
2. The potential of cerebrospinal fluid-based liquid biopsy approaches in CNS tumors.
Mattox AK; Yan H; Bettegowda C
Neuro Oncol; 2019 Dec; 21(12):1509-1518. PubMed ID: 31595305
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies.
Schmid D; Warnken U; Latzer P; Hoffmann DC; Roth J; Kutschmann S; Jaschonek H; Rübmann P; Foltyn M; Vollmuth P; Winkler F; Seliger C; Felix M; Sahm F; Haas J; Reuss D; Bendszus M; Wildemann B; von Deimling A; Wick W; Kessler T
J Neurochem; 2021 Jul; 158(2):522-538. PubMed ID: 33735443
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors.
Samuel N; Remke M; Rutka JT; Raught B; Malkin D
J Neurooncol; 2014 Jun; 118(2):225-238. PubMed ID: 24771250
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid biomarkers of malignancies located in the central nervous system.
Verheul C; Kleijn A; Lamfers MLM
Handb Clin Neurol; 2017; 146():139-169. PubMed ID: 29110768
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal Fluid biomarkers in pediatric brain tumors: A systematic review.
Lehner KR; Jiang K; Rincon-Torroella J; Perera R; Bettegowda C
Neoplasia; 2023 Jan; 35():100852. PubMed ID: 36516487
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid circulating tumour DNA as a liquid biopsy for central nervous system malignancies.
Escudero L; Martínez-Ricarte F; Seoane J
Curr Opin Neurol; 2020 Dec; 33(6):736-741. PubMed ID: 33177377
[TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review.
Nayak L; Bettegowda C; Scherer F; Galldiks N; Ahluwalia M; Baraniskin A; von Baumgarten L; Bromberg JEC; Ferreri AJM; Grommes C; Hoang-Xuan K; Kühn J; Rubenstein JL; Rudà R; Weller M; Chang SM; van den Bent MJ; Wen PY; Soffietti R
Neuro Oncol; 2024 Jun; 26(6):993-1011. PubMed ID: 38598668
[TBL] [Abstract][Full Text] [Related]
9. CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma.
Galicia N; Dégano R; Díez P; González-González M; Góngora R; Ibarrola N; Fuentes M
Expert Rev Proteomics; 2017 Apr; 14(4):363-372. PubMed ID: 28293970
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors.
Kopkova A; Sana J; Fadrus P; Slaby O
Clin Chem Lab Med; 2018 May; 56(6):869-879. PubMed ID: 29451858
[TBL] [Abstract][Full Text] [Related]
11. The Utility of Liquid Biopsy in Central Nervous System Malignancies.
Nevel KS; Wilcox JA; Robell LJ; Umemura Y
Curr Oncol Rep; 2018 Jun; 20(8):60. PubMed ID: 29876874
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies.
Shalaby T; Grotzer MA
Int J Mol Sci; 2015 Dec; 16(12):29103-19. PubMed ID: 26690130
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry-based proteomics of cerebrospinal fluid in pediatric central nervous system malignancies: a systematic review with meta-analysis of individual patient data.
Mirian C; Thastrup M; Mathiasen R; Schmiegelow K; Olsen JV; Østergaard O
Fluids Barriers CNS; 2024 Feb; 21(1):14. PubMed ID: 38350915
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).
Sasayama T; Nakamizo S; Nishihara M; Kawamura A; Tanaka H; Mizukawa K; Miyake S; Taniguchi M; Hosoda K; Kohmura E
Neuro Oncol; 2012 Mar; 14(3):368-80. PubMed ID: 22156547
[TBL] [Abstract][Full Text] [Related]
15. A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies.
Drusco A; Bottoni A; Laganà A; Acunzo M; Fassan M; Cascione L; Antenucci A; Kumchala P; Vicentini C; Gardiman MP; Alder H; Carosi MA; Ammirati M; Gherardi S; Luscrì M; Carapella C; Zanesi N; Croce CM
Oncotarget; 2015 Aug; 6(25):20829-39. PubMed ID: 26246487
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as biomarkers for central nervous system malignancies.
Zorofchian S; Iqbal F; Rao M; Aung PP; Esquenazi Y; Ballester LY
J Clin Pathol; 2019 Apr; 72(4):271-280. PubMed ID: 30467241
[TBL] [Abstract][Full Text] [Related]
17. Quantification of cerebrospinal fluid ferritin as a biomarker for CNS malignant infiltration.
Almeida SM; Cunha DS; Yamada E; Doi EM; Ono M
Arq Neuropsiquiatr; 2008 Sep; 66(3B):720-4. PubMed ID: 18949270
[TBL] [Abstract][Full Text] [Related]
18. Lipid-associated sialoprotein in the cerebrospinal fluid: association with brain malignancies.
Katopodis N; Glantz MJ; Kim L; Dafni U; Wu JK; Perides G
Cancer; 2001 Aug; 92(4):856-62. PubMed ID: 11550158
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.
Shen F; Zhang Y; Yao Y; Hua W; Zhang HS; Wu JS; Zhong P; Zhou LF
Neurosurg Rev; 2014 Jul; 37(3):367-80; discussion 380. PubMed ID: 24781189
[TBL] [Abstract][Full Text] [Related]
20. Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors.
Bunda S; Zuccato JA; Voisin MR; Wang JZ; Nassiri F; Patil V; Mansouri S; Zadeh G
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
